Wockhardt stock up 10% as Zaynich achieves 96.8% efficacy in Phase III
Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...
Parkersburg News and Sentinel15m
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
ASX Runners of the Week: Bio-Gene, Alterity, Aston & Canterbury
Gene Technology (ASX:BGT) 153pc up (from 2.8c to 7.1c)This week’s Bulls N’ Bears ASX Runner of the Week is Bio-Gene Technology, which revealed on Wednesday it scored a slice of two United States ...